ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,843Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 198

$6.25M Total Retail Price of All Prescriptions

Rank: 1 out of 198

283 Patients Receiving at Least One Drug in Part D
8%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 283 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 841 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

61% of this provider’s prescriptions were for brand-name drugs, compared to an average of 47%.

Prescription Price

$528 was the average price of a prescription from this provider, compared to $351 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
NORVIR 1,057 66 10 1 1
ISENTRESS 836 40 10 2 3
TRUVADA 716 11 10 3 2
PREZISTA 669 28 10 4 4
EPZICOM 436 70 10 5 10
GABAPENTIN 382 13 6 21
ATRIPLA 362 22 10 7 5
KALETRA 332 14 10 8 19
REYATAZ 331 38 9 8
TRAMADOL HCL 319 18 10 42
LAMIVUDINE-ZIDOVUDINE 230 30 10 11 80
SULFAMETHOXAZOLE-TRIMETHOPRIM 219 23 12 13
LISINOPRIL 218 32 13 6
PROAIR HFA 210 0 14 43
VIREAD 185 25 15 31
INTELENCE 182 12 16 20
LOPERAMIDE 154 13 17 129
ATORVASTATIN CALCIUM 142 18 18 22
METOPROLOL TARTRATE 127 18 19 24
DRONABINOL 126 0 10 20 61
LAMIVUDINE 125 28 10 21 111
SUSTIVA 123 53 22 56
TESTOSTERONE CYPIONATE 121 0 S3 23 90
AZITHROMYCIN 119 0 24 23
ENALAPRIL MALEATE 116 0 25 47
TRAZODONE HCL 115 0 26 65
PRAVASTATIN SODIUM 104 12 27 28
ACYCLOVIR 104 0 27 29
MEDROXYPROGESTERONE ACETATE 102 0 29 183
LEXIVA 101 0 30 53
OMEPRAZOLE 98 14 31 7
SPIRONOLACTONE 92 0 32 113
SERTRALINE HCL 89 0 33 46
MEPRON 87 0 10 34 162
ZIAGEN 80 0 35 109
RANITIDINE HCL 69 24 36 34
SELZENTRY 66 0 37 89
BARACLUDE 65 0 38 203
LIPITOR 63 0 39 130
DAPSONE 60 0 40 139
AMLODIPINE BESYLATE 59 12 41 12
EMTRIVA 58 13 42 85
FUROSEMIDE 57 0 43 24
METOCLOPRAMIDE HCL 56 0 44 226
VIRACEPT 56 0 44 175
VIRAMUNE XR 55 14 46 155
CYPROHEPTADINE HCL 51 0 R 47 183
STAVUDINE 50 0 10 48 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.